Asako Doi
Kobe University
29 Papers
69 Citations
Asako Doi is an academic researcher from Kobe University. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 11, co-authored 29 publications.
Chat about Author
Papers
Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis.
Kentaro Iwata,Asako Doi,Goh Ohji,Hideaki Oka,Yuichiro Oba,Kohei Takimoto,Wataru Igarashi,David H. Gremillion,Toshihiko Shimada +8 more
TL;DR: Sivelestat was not associated with decreased mortality, even when including studies published in Japanese language, despite being widely used in Japan for the treatment of acute lung injury and acute respiratory distress syndrome.
173
Clinical and Molecular Characteristics of Klebsiella pneumoniae Isolates Causing Bloodstream Infections in Japan: Occurrence of Hypervirulent Infections in Health Care.
Sohei Harada,Sohei Harada,Sohei Harada,Kotaro Aoki,Shungo Yamamoto,Yoshikazu Ishii,Noritaka Sekiya,Hanako Kurai,Keiichi Furukawa,Asako Doi,Kentaro Tochitani,Kenji Kubo,Yukihiro Yamaguchi,Masashi Narita,Shinya Kamiyama,Jun Suzuki,Takahiko Fukuchi,Yoshiaki Gu,Keiji Okinaka,Soichi Shiiki,Kayoko Hayakawa,Natsuo Tachikawa,Kei Kasahara,Tadahiro Nakamura,Kyoko Yokota,Masanari Komatsu,Misaki Takamiya,Kazuhiro Tateda,Yohei Doi +28 more
TL;DR: Clinical and molecular characteristics of K. pneumoniae bloodstream infections from hospitals across Japan were analyzed by a review of the medical records and revealed that patients with hvKp infections had higher proportions of diabetes mellitus, and their infections had significantly higher propensity to involve pneumonia.
89
The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae
TL;DR: Cefmetazole may be a useful option for the treatment of UTIs caused by ESBL-producing organisms and Prospective and larger sized studies are needed to confirm the findings.
82
Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study.
Asako Doi,Kentaro Iwata,Hirokazu Kuroda,Toshikazu Hasuike,Seiko Nasu,Aya Kanda,Tomomi Nagao,Hiroaki Nishioka,Keisuke Tomii,Takeshi Morimoto,Yasuki Kihara +10 more
TL;DR: In this paper, a cross-sectional serological study suggests that the number of people with seropositive for SARS-CoV-2 infection in Kobe, Japan is far more than the confirmed cases by PCR testing.
60